The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Density patterns of tumor-infiltrating lymphocytes and association with objective response to nivolumab in patients with lung adenocarcinoma from CheckMate 057.
 
Germán Corredor
No Relationships to Disclose
 
Ruiwen Ding
No Relationships to Disclose
 
Prateek Prasanna
Patents, Royalties, Other Intellectual Property - Patent number: 10970838 Patent number: 10943348
 
Cristian Barrera
No Relationships to Disclose
 
Paula Toro
No Relationships to Disclose
 
Vidya Sankar Viswanathan
Stock and Other Ownership Interests - Pfizer
 
Philipp Zens
Other Relationship - Swiss Cancer Research Foundation
 
Sabina Berezowska
Consulting or Advisory Role - Lilly
Research Funding - Roche (Inst)
 
Vipul Baxi
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David Balli
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Merzu Belete
No Relationships to Disclose
 
Vamsidhar Velcheti
Honoraria - ITeos Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; GlaxoSmithKline; Lilly; Merck; Novartis
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)
 
Kurt A. Schalper
Consulting or Advisory Role - Agenus; Clinica Alemana; Dynamo Therapeutics; EMD Serono; Excite International; Merck; Ono Pharmaceutical; Pierre Fabre; Shattuck Labs; Takeda; Torque
Speakers' Bureau - Bristol-Myers Squibb; BTIG; Fluidigm; Genmab; Merck; Peerview; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Moderna Therapeutics; Navigate BioPharma; Pierre Fabre; Ribon Therapeutics; Surface Oncology; Takeda; Tesaro
Patents, Royalties, Other Intellectual Property - Patent No. 16/464,010 (PREDICTION OF RESPONSE TO IMMUNE-MODULATORY THERAPIES)
 
Anant Madabhushi
Leadership - Inspirata
Stock and Other Ownership Interests - Elucid Bioimaging; Inspirata
Honoraria - AstraZeneca; Inspirata
Consulting or Advisory Role - Aiforia; Caris Life Sciences; Cernostics; Merck; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol Myers-Squibb (Inst); Inspirata (Inst); Philips Healthcare (Inst)
Patents, Royalties, Other Intellectual Property - IP Licensed by Elucid Bioimaging (Inst); IP licensed by Inspirata Inc. (Inst)